NASDAQ:OTLK | Free Cash Flow | Outlook Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-09-30 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$14.94M
2025-09-30-$12.38M
2024-12-31-$10.97M
2024-09-30-$16.98M
2023-12-31-$13.03M
2023-09-30-$12.74M
2022-12-31-$8.9M
2022-09-30-$10.25M
2021-12-31-$10.99M
2021-09-30-$8.99M
2020-12-31-$13.32M
2020-09-30-$12.08M
2019-12-31-$6.67M
2019-09-30-$5.94M$1.00-$5.94M
2018-12-31-$9.78M$236,433.00-$10.02M
2018-09-30-$8.39M$1.26M-$9.66M
2017-12-31-$8.67M$1.08M-$9.75M
2017-09-30$79,854.00$23,980.00$55,874.00
2016-12-31-$5.84M$148,362.00-$5.99M
2016-09-30-$10.37M$328,411.00-$10.7M
2015-12-31-$12.01M$364,242.00-$12.38M
2015-09-30-$11.01M$3.29M-$14.31M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$51.83M
2024-09-30-$68.79M
2023-09-30-$42.97M
2022-09-30-$56.67M
2021-09-30-$54.25M
2020-09-30-$31.79M
2019-09-30-$32.29M$437,307.00-$32.73M
2018-09-30-$33.04M$2.78M-$35.82M
2017-09-30-$15.51M$292,086.00-$15.8M
2016-09-30-$45.48M$1.1M-$46.58M
2015-09-30-$27.48M$8.8M-$36.28M